Efficacy of Local Drug Delivery Agents as an Adjunct to Scaling and Root Planing for Treating Furcation Defects in Chronic Periodontitis - A Systematic Review Protocol
DOI:
https://doi.org/10.61841/zhhv0k54Abstract
Periodontal disease is a chronic inflammatory disease initiated by dental plaque. Periodontitis affects the periodontium as a whole. It leads to destruction of alveolar bone and ultimately tooth loss. Chronic periodontitis affects the root trunk of multirooted teeth commonly leading to furcation defect. Pharmacologic management of chronic periodontitis is used as an adjunct to conventional scaling and root planing (SRP). It includes chlorhexidine mouth rinses, subgingival irrigation and local drug delivery agents. Potential therapeutic agents such as non-steroidal anti‑inflammatory drugs, chemically modified tetracyclines, and bisphosphonates to treat bone resorption are well documented in periodontal literature. However, the role of local drug delivery agents (LDD) as an adjunct to scaling and root planing needs further exploration and research. The aim of this systematic review will be to determine the efficacy of the currently available local drug delivery agents as an adjunct to scaling and root planing for the treatment of furcation defects in chronic periodontitis
Downloads
References
1. Ipshita S, Kurian IG, Dileep P, Kumar S, Singh P, Pradeep AR. One percent alendronate and aloe vera gel local host modulating agents in chronic periodontitis patients with class II furcation defects: A randomized, controlled clinical trial. J Investig Clin Dent. 2018 Aug;9(3):e12334–e12334.
2. Graves D. Cytokines That Promote Periodontal Tissue Destruction. J Periodontol. 2008 Aug;79(8s):1585– 91.
3. Pradeep AR, Agarwal E, Naik SB. Clinical and microbiologic effects of commercially available dentifrice containing aloe vera: a randomized controlled clinical trial. J Periodontol. 2012 Jun;83(6):797–804.
4. Gupta RK, Gupta D, Bhaskar DJ, Yadav A, Obaid K, Mishra S. Preliminary antiplaque efficacy of aloe vera mouthwash on 4 day plaque re-growth model: randomized control trial. Ethiop J Health Sci. 2014 Apr;24(2):139–44.
5. Tonetti MS, Lang NP, Cortellini P, Suvan JE, Eickholz P, Fourmousis I, et al. Effects of a single topical doxycycline administration adjunctive to mechanical debridement in patients with persistent/recurrent
periodontitis but acceptable oral hygiene during supportive periodontal therapy. J Clin Periodontol. 2012 May;39(5):475–82.
6. Hussein I, Ranka M, Gilbert A, Davey K. Locally Delivered Antimicrobials in the Management of Periodontitis: A Critical Review of the Evidence for their Use in Practice. Dent Update. 2007 Oct 2;34(8):494–506.
7. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016 Dec;5(1):210.
8. Moher D, Liberati A, Tetzlaff J, Altman DG, for the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009 Jul 21;339(jul21 1):b2535– b2535.
9. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011 Apr;64(4):401–6.
10. Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011 Oct 18;343(oct18 2):d5928–d5928.
11. Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross- over trials: methodological issues. Int J Epidemiol. 2002 Feb;31(1):140–9.
12. Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011 Feb 10;342(feb10 2):d549–d549.
13. Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017 13;1:CD007393.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
